← Eichor
Condition: Gastric Adenoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Gastric Adenoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Phase N/A · 2 location(s) · Vanderbilt University Medical Center · NCT00899626
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Includi
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06885697
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Phase 1 · 9 location(s) · RayzeBio, Inc. · NCT07165132
A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 · 17 location(s) · Nurix Therapeutics, Inc. · NCT05107674
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
Phase N/A · 4 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06822413
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06503146
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01950572
A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adeno
Phase N/A · 2 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT04677998
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
NA · 1 location(s) · Algemeen Ziekenhuis Maria Middelares · NCT06835426
Clinical Application of Genetic Sequencing of Early Gastric Cancer and Gastric Adenoma Patients
Phase N/A · 1 location(s) · Samsung Medical Center · NCT04665687
A Beta-only IL-2 ImmunoTherapY Study
Phase 1/Phase 2 · 27 location(s) · Medicenna Therapeutics, Inc. · NCT05086692
Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)
NA · 3 location(s) · Samsung Medical Center · NCT07161479
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Phase 1 · 3 location(s) · SHY Therapeutics · NCT07705334
New bioMarkers tO straTIfy cOlorectal caNcer Referrals
Phase N/A · 1 location(s) · Queen Mary University of London · NCT07035691
Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699
Video Tutorial and Oral Explanation Vs Oral Explanation Alone in Colonoscopy Preparation
NA · 5 location(s) · Centre Hospitalier Saint Joseph Saint Luc de Lyon · NCT07355777
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Phase 1/Phase 2 · 11 location(s) · Perspective Therapeutics · NCT06710756
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 17
Phase 3 · 54 location(s) · RayzeBio, Inc. · NCT05477576
Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract,
Phase 2 · 4 location(s) · Aadi Bioscience, Inc. · NCT05997056
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/Phase 2 · 5 location(s) · Cancer Research UK · NCT05944237
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.